Ginkgo Bioworks Holdings, Inc. · NYSE:DNA
Kelly Jason R sold 206,782 Ginkgo Bioworks Holdings, Inc. shares (Form 4)
Traded Apr 7 to Apr 9, 2026 · Filed Apr 10, 2026
From Apr 7 to Apr 9, 2026, Kelly Jason R (Director, See remarks) sold 206,782 Ginkgo Bioworks Holdings, Inc. shares at an average US$6.65 for US$1.37M, leaving 316,483 shares. Filed Apr 10, 2026 (Form 4).
- Sold
- 206,782 shares
- Price
- US$6.65 average (US$6.40 to US$6.93)
- Value
- US$1.37M
- Holding after
- 316,483 shares
- Trading plan
- No
- Role
- Director, See remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Class A Common Stock | Option exercise | 212,949 | 310,316 | Direct | |
| Apr 8, 2026 | Class A Common Stock | Option exercise | 212,949 | 523,265 | Direct | |
| Apr 8, 2026 | Class A Common Stock | Sale | 97,015 | US$6.93 | 426,250 | Direct |
| Apr 9, 2026 | Class A Common Stock | Sale | 109,767 | US$6.40 | 316,483 | Direct |
Source
Related
- Ginkgo Bioworks Holdings, Inc.
- Kelly Jason R
- Ginkgo Bioworks Holdings, Inc. shareholders
- Form 4 · Kelly Jason R · Oct 21, 2026
- Form 4 · Coen Steven P. · Oct 21, 2026
- Form 4 · Canton Barry · Oct 21, 2026
- Form 4 · Shetty Reshma P. · Oct 21, 2026
- Form 4 · Coen Steven P. · Oct 7, 2026
- Form 4 · Henry Christian O · Sep 16, 2026